Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pain Catastrophizing and Routine Assessment of Patient Index Data 3(RAPID3) in Ten Categories of Rheumatology Outpatients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03306784
Recruitment Status : Recruiting
First Posted : October 11, 2017
Last Update Posted : October 11, 2017
Sponsor:
Information provided by (Responsible Party):
Nantes University Hospital

Brief Summary:
Fulfilling by all patients consequently seen by 6 rheumatologists in a same outpatient rheumatology clinic (in at least one month period) of a set of 6 questionnaires, including RAPID3 and pain catastrophizing scales.

Condition or disease Intervention/treatment
Arthritis, Rheumatoid Spondyloarthritis Inflammatory Rheumatisms Systemic Disorders Other: questionnaires

Detailed Description:
Fulfilling by all patients (seen by 6 rheumatologists in a same outpatient rheumatology clinic from a university French hospital in at least one month period) of a set of 6 questionnaires including a RAPID3 score (Routine Assessment of Patient Index Data 3) and pain catastrophizing scale, as well as Pain detect and Hospital Anxiety and Depression scale questionnaires (HAD) , in ten predefined categories of disorders: rheumatoid arthritis; any spondyloarthritis; other inflammatory rheumatisms or systemic disorders; osteoarthritis of the upper part of the body; osteoarthritis of the lower part of the body; back pain and/or radiculalgia; bone disorders, including osteoporosis; tendinosis and other soft tissue conditions; peripheral neuropathy, including entrapment neuropathies; fibromyalgia and related conditions.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Transversal Study of Correlations Between Pain Catastrophizing Scale (PCS) and RAPID3 Score According to Ten Categories of Conditions Seen in an Outpatient Rheumatology Clinic
Actual Study Start Date : July 3, 2017
Estimated Primary Completion Date : July 2018
Estimated Study Completion Date : July 2018

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: questionnaires
    questionnaires, including RAPID3 and pain catastrophizing scales


Primary Outcome Measures :
  1. Ranking of PCS scores according to the underlying disorders (10 predefined categories), and also ranking of RAPID-3 scores according to the underlying disorders (10 predefined categories). [ Time Frame: At least one month for each physician, and at least 30 patients in each category (whatever the physician seen). ]
    Composite score: RAPID3 (0-30) and PCS (0-52) are widely used scales, suitable for routine fulfillment by outpatients.


Secondary Outcome Measures :
  1. Ranking of correlations between RAPID3 and Pain catastrophizing scale (PCS) (13 items) scores in the 10 subsets of categories listed above (from the strongest correlation to the lowest correlation) [ Time Frame: At least one month for each physician, and at least 30 patients in each category (whatever the physician seen). ]
    RAPID3 (0-30) and PCS (0-52) are widely used scales, suitable for routine fulfillment by outpatients



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
300 Men or women coming to the Rheumatology Department of the Nantes University Hospital with a senior rheumatologist agreeing to fulfil the set of 6 questionnaires
Criteria

Inclusion Criteria:

  • any outpatient aged 18 or more, agreeing to fulfil the set of 6 questionnaires
  • Man or woman coming to the Rheumatology Department of the Nantes University Hospital with a senior rheumatologist

Exclusion Criteria:

  • Patients not fluent enough in French or suffering from neurological or psychological disorders making their responses unreliable

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03306784


Contacts
Layout table for location contacts
Contact: Jean-Marie Berthelot, Dr 02.40.08 48.22 jeanmarie.berthelot@chu-nantes.fr
Contact: Peggy Ageneau 02 40 08 48 54 peggy.ageneau@chu-nantes.fr

Locations
Layout table for location information
France
CHU de Nantes Recruiting
Nantes, France, 44093
Contact: jean-marie Berthelot, Dr    02 40 08 48 22    jeanmarie.berthelot@chu-nantes.fr   
Contact: peggy Ageneau    02 40 08 48 54    peggy.ageneau@chu-nantes.fr   
Sponsors and Collaborators
Nantes University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Jean-Marie Berthelot, Dr CHU de NANTES

Layout table for additonal information
Responsible Party: Nantes University Hospital
ClinicalTrials.gov Identifier: NCT03306784     History of Changes
Other Study ID Numbers: RC17_0182
First Posted: October 11, 2017    Key Record Dates
Last Update Posted: October 11, 2017
Last Verified: July 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Nantes University Hospital:
RAPID3
pain catastrophizing

Additional relevant MeSH terms:
Layout table for MeSH terms
Streptococcal Infections
Spondylarthritis
Arthritis, Rheumatoid
Rheumatic Diseases
Rheumatic Fever
Spondylitis
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases
Arthritis
Joint Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases
Gram-Positive Bacterial Infections
Bacterial Infections